Alan Kotok

A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.

https://sciencebusiness.technewslit.com/?p=45448

#News #Press #Science #Business #Regulatory #ClinicalTrial #Biotechnology #UK #Germany #mRNA #Lungs #Respiratory #Inhaled #Lipid #Nanoparticles #Immune

Trial Set to Test Inhaled mRNA for Viral Infections

A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.

Science and Enterprise
Nov 28, 2023 at 5:16pmWeb